StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Rajesh Satpute

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

byRajesh SatputeHorizon: Swing (≤2wk)18 Jun 2026via CNBC Awaaz.

Entry₹1,820.5Inferred
Target₹1,860
Total upside +2.17% (call closed)
Stop loss₹1,800-1.13% risk
Exit₹1,86022 Jun 2026, 1:10 pm
Target hit+2.17%0.00%upside left
Follow Rajesh Satpute for new calls(32% target hit, 200 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 9:34 pm IST
2 supporting0 opposing
Supports the BUY call (2)

Sun Pharma to acquire Innovcare Lifesciences for ₹271.2 crore

NewsGoogle News·21 Jun · yesterday

(opens in new tab)

Sun Pharma has entered into an agreement to acquire 100% outstanding shares of Innovcare Lifesciences Private Limited for approximately Rs 271.2 Crores. Innovcare is engaged in marketing, distribution

BSE · Company Update·20 Jun · yesterday

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Rajesh Satpute

Every call and its outcome